Skip to main content
. Author manuscript; available in PMC: 2011 Apr 5.
Published in final edited form as: Drug Deliv. 2009 Jan;16(1):45–51. doi: 10.1080/10717540802517951

FIG. 6.

FIG. 6

(A) The cytotoxicity towards U87MG cells of mAb 2C5-modified DM-PIT-1-loaded PEG-PE micelles (1) compared to mAb 2C5-free preparation (2); (B) Same as in (A) but in the presence of the soluble TRAIL at 50 ng/ml. Cell viability was determined using the MTT assay. Viability of cells in the presence of plain micelles, immunomicelles and TRAIL was observed at comparable concentrations of drug-loaded particles. Data represent the mean ± SD of three independent experiments and are expressed relative to the untreated control (* P< 0.05, ** P< 0.01).